Anxiety/Depression Linked to HRQoL Losses in Seropositive RA
By Elana Gotkine HealthDay Reporter
MONDAY, Nov. 4, 2024 -- Patients with seropositive rheumatoid arthritis (RA) with moderate and extreme anxiety/depression have mean health-related quality-of-life (HRQoL) losses, regardless of pain and discomfort, according to a study published online Oct. 30 in Clinical Rheumatology.
Diego Fernando Rojas‑Gualdrón, from the Universidad CES in Medellín, Colombia, and colleagues conducted a data analysis on a registry-based retrospective follow-up study of patients with seropositive RA treated between August 2014 and January 2023. The authors sought to examine the HRQoL loss associated with self-perceived anxiety/depression. A total of 3,579 patients were included, with a mean follow-up of 2.9 years.
The researchers found that 6.6 percent of the participants reported extreme anxiety/depression at program admission. Per year lived with seropositive RA, the average HRQoL loss was 3.4 months. Moderate and extreme anxiety/depression were associated with mean HRQoL losses of 2.2 and 4.1 months, respectively, among patients with no pain and discomfort, and with losses of 0.8 and 1.9 months, respectively, for patients with extreme pain/discomfort.
"These findings highlight the importance of strengthening mental health care and psychological well-being interventions for patients with RA, regardless of pain or disease activity," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted November 2024
Read this next
One in 10 Mental Health-Related ED Visits Among Youths Involve Boarding
WEDNESDAY, Aug. 20, 2025 -- Boarding is a considerable issue for Medicaid-enrolled youths seeking mental health care in emergency departments (EDs), according to a research letter...
College Students With Autism Report Higher Rates of Anxiety, Depression
TUESDAY, Aug. 19, 2025 -- College students with autism face higher rates of anxiety and depression than students without autism, according to a study recently published online in...
ADHD Drug Treatment Linked to Reduced Rate of Adverse Outcomes
THURSDAY, Aug. 14, 2025 -- Attention-deficit/hyperactivity disorder (ADHD) drug treatment is associated with reduced rates of adverse outcome events, including suicidality...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.